Innovation one of 33 shortlisted from over 150 applications got under ICMR-NIN INFUSE initiative. Study protocol published preprint last April, intended product is a smartphone app.
The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.
The affidavit is the government's third submission to the SC in response to a writ petition filed by social worker Harisharan Devgan & others challenging the January cut-off revision.
Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.
Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.
New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.
Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.
I spent a year as an international student in Melbourne and experienced racism first-hand, which made me second-guess and shrink parts of myself just to go about everyday life.
The shipment earlier bound for Gujarat’s Vadinar has changed course amid payment concerns; could still reach India if issues are resolved, according to Kpler.
INS Arihant was first vessel under SSBN project and was quietly commissioned in 2016. The second indigenous SSBN, INS Arighat, was commissioned in August 2024.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS